retatrutide side effects trial results Lilly orforglipron oral GLP-1 phase 3 weight loss retatrutide weight loss clinical trials

Trial data showed that participants who remained compliant through plateau periods eventually achieved similar weight loss to those who experienced steady linear loss

It is helpful in monitoring other health markers, ensuring that everything is trending in the right direction

As retatrutide remains unlicensed in the UK and is not approved by the MHRA or EMA, it is only accessible through regulated clinical trials

But your choice will also be based on what fits your lifestyle and budget

J Cardiol

The triple-receptor approach appears to produce more significant results than single-target medications in some individuals